2025 France Apheresis Market Revenue Opportunities Report
Description
The 2025 France Apheresis Market Revenue Opportunities Report features 1) market size data for the region or country, 2) annual market growth rates, 3) the market's impact on related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing, 4) Total Addressable Market (TOM) for the four largest market players, 5) Serviceable Addressable Market (SAM), and 6) Serviceable Obtainable Market (SOM)(Wharry Sharpe Research)
The Revenue Opportunities Reports provide market size data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for the region or country. The report also features written analysis on market definitions, and market segments.
Market and product shipments include the total value of all products produced and shipped by all producers (also described as value of receipts, value of production, or value of work done.)
The report features written analysis and market size statistics on opportunities created in the Apheresis Market by the changing related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing,
The four largest companies actively participating in the apheresis market in France are Haemonetics Corporation, Fresenius SE & Co. KGaA, Terumo BCT, Inc., and Asahi Kasei Medical Co., Ltd. These companies dominate the market with their advanced apheresis devices and disposable kits, catering both to donor collection and therapeutic procedures. Haemonetics offers innovative solutions for plasmapheresis, plateletpheresis, and leukapheresis, and has a significant operational footprint in Europe, including France. Fresenius, through its divisions Fresenius Medical Care and Fresenius Kabi, provides a comprehensive portfolio of apheresis products and invests heavily in R&D for blood purification and extracorporeal therapies. Terumo BCT focuses on expanding its market reach with efficient and safe apheresis technologies globally, including in France. Asahi Kasei Medical also plays a major role with its apheresis product portfolio targeting various transfusion needs.
These companies benefit from France's growing apheresis market, which generated approximately USD 136.9 million in revenue in 2023 and is expected to grow at a CAGR of 9.6% through 2030, driven by rising demand for blood components and chronic disease prevalence. The market's fastest growth is seen in devices and disposable apheresis kits, segments dominated by these key players. Moreover, French market conditions, including regulatory challenges like the suspension of Haemonetics' blood collection device in 2018, have stimulated competitive positioning by emphasizing product safety and reliability. Smaller local leaders such as Hema.T Medical also specialize in therapeutic apheresis and rheopheresis, contributing to the regional landscape primarily in France itself. Overall, these four multinational corporations are pivotal to France’s expanding apheresis sector through innovative technologies and strategic market presence.
Revenue Opportunities are defined by the measurements of Total Addressable Market (TOM) for the four largest market players, Serviceable Addressable Market (SAM), and Serviceable Obtainable Market (SOM). The measurements include both written analysis and current calculations for each company in the market for each country or region.
This report does not provide the names of companies in the market or written analysis of each market's trends within each country to provide a cost-effective report that focuses solely on the statistics and data on each market.
Wharry Sharpe Research publishes thousands of market analysis and product research report annually to assist their clients with the essential data they need for the market research, budgeting and forecasting needs.
The Revenue Opportunities Reports provide market size data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for the region or country. The report also features written analysis on market definitions, and market segments.
Market and product shipments include the total value of all products produced and shipped by all producers (also described as value of receipts, value of production, or value of work done.)
The report features written analysis and market size statistics on opportunities created in the Apheresis Market by the changing related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing,
The four largest companies actively participating in the apheresis market in France are Haemonetics Corporation, Fresenius SE & Co. KGaA, Terumo BCT, Inc., and Asahi Kasei Medical Co., Ltd. These companies dominate the market with their advanced apheresis devices and disposable kits, catering both to donor collection and therapeutic procedures. Haemonetics offers innovative solutions for plasmapheresis, plateletpheresis, and leukapheresis, and has a significant operational footprint in Europe, including France. Fresenius, through its divisions Fresenius Medical Care and Fresenius Kabi, provides a comprehensive portfolio of apheresis products and invests heavily in R&D for blood purification and extracorporeal therapies. Terumo BCT focuses on expanding its market reach with efficient and safe apheresis technologies globally, including in France. Asahi Kasei Medical also plays a major role with its apheresis product portfolio targeting various transfusion needs.
These companies benefit from France's growing apheresis market, which generated approximately USD 136.9 million in revenue in 2023 and is expected to grow at a CAGR of 9.6% through 2030, driven by rising demand for blood components and chronic disease prevalence. The market's fastest growth is seen in devices and disposable apheresis kits, segments dominated by these key players. Moreover, French market conditions, including regulatory challenges like the suspension of Haemonetics' blood collection device in 2018, have stimulated competitive positioning by emphasizing product safety and reliability. Smaller local leaders such as Hema.T Medical also specialize in therapeutic apheresis and rheopheresis, contributing to the regional landscape primarily in France itself. Overall, these four multinational corporations are pivotal to France’s expanding apheresis sector through innovative technologies and strategic market presence.
Revenue Opportunities are defined by the measurements of Total Addressable Market (TOM) for the four largest market players, Serviceable Addressable Market (SAM), and Serviceable Obtainable Market (SOM). The measurements include both written analysis and current calculations for each company in the market for each country or region.
This report does not provide the names of companies in the market or written analysis of each market's trends within each country to provide a cost-effective report that focuses solely on the statistics and data on each market.
Wharry Sharpe Research publishes thousands of market analysis and product research report annually to assist their clients with the essential data they need for the market research, budgeting and forecasting needs.
Table of Contents
51 Pages
- A. Definitions
- A1. Market Definition
- A2. Market Segmentation
- A3. Industry Opportunities-Industry1
- A4. Industry Opportunities-Industry2
- A5. Industry Opportunities-Industry3
- B. Total Addressable Market (TAM)
- B1. TAM-Player 1/4
- B2. TAM-Player 2/4
- B3. TAM-Player 3/4
- B4. TAM-Player 4/4
- C. Serviceable Addressable Market (SAM)
- C1. SAM-Player 1/4
- C2. SAM-Player 2/4
- C3. SAM-Player 3/4
- C4. SAM-Player 4/4
- D. Serviceable Obtainable Market (SOM)
- D1. SOM-Player 1/4
- D2. SOM-Player 2/4
- D3. SOM-Player 3/4
- D4. SOM-Player 4/4
- E. Appendix
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
